How should vancomycin be dosed (including loading dose, maintenance dose, infusion duration, and trough monitoring) for a 68‑year‑old, 63‑kg patient with a corrected serum creatinine of 72 µmol/L (≈0.82 mg/dL)?

Vancomycin Dosing for a 68-Year-Old, 63-kg Patient with SCr 72 µmol/L

For this patient with normal renal function (CrCl approximately 70-80 mL/min based on age, weight, and SCr 72 µmol/L ≈ 0.82 mg/dL), initiate vancomycin with a loading dose of 25-30 mg/kg (1575-1890 mg, rounded to 1500-2000 mg) infused over 2 hours, followed by maintenance dosing of 15-20 mg/kg every 12 hours (approximately 1000 mg every 12 hours), targeting trough levels of 15-20 mg/L for serious infections. 1

Creatinine Clearance Calculation

Using the Cockcroft-Gault equation for this patient: 2

For a 68-year-old female (assuming female given lower body weight):

• CrCl = 0.85 × [(63 kg × (140 - 68)] / (72 × 0.82) = approximately 73 mL/min 2

For a 68-year-old male:

• CrCl = [(63 kg × (140 - 68)] / (72 × 0.82) = approximately 77 mL/min 2

Critical consideration: Do not round the SCr to 1.0 mg/dL in elderly patients with actual values <1 mg/dL, as this leads to significant underestimation of CrCl and inaccurate dosing—using actual SCr resulted in mean differences of 6.15 μg/mL in females and 2.92 μg/mL in males between predicted and measured trough concentrations. 3

Loading Dose Strategy

Administer a loading dose of 25-30 mg/kg (1575-1890 mg, practical dose: 1500-2000 mg) to rapidly achieve therapeutic concentrations. 1

• Infuse over 2 hours (not faster than 10 mg/min) to minimize red man syndrome risk 1, 2
• Consider antihistamine premedication 1
• Loading doses are particularly important in critically ill patients but beneficial for all serious infections 1

Maintenance Dosing

Based on CrCl of approximately 70-80 mL/min, the maintenance dose should be 15-20 mg/kg every 12 hours (approximately 945-1260 mg, practical dose: 1000 mg every 12 hours). 1, 2

Using the FDA dosing table for renal function: 2

• CrCl 70 mL/min = approximately 1080 mg/24 hours
• CrCl 80 mL/min = approximately 1235 mg/24 hours
• This translates to 500-625 mg every 12 hours or 1000 mg every 12 hours for serious infections 2

Each maintenance dose must be infused over at least 60 minutes, at a rate not exceeding 10 mg/min. 2

Target Trough Concentrations

For serious MRSA infections (bacteremia, endocarditis, osteomyelitis, meningitis, hospital-acquired pneumonia), target trough concentrations of 15-20 mg/L to achieve AUC/MIC ratio ≥400 for organisms with MIC ≤1 mg/L. 1

• This range balances efficacy against nephrotoxicity risk 1
• Sustained trough concentrations >20 μg/mL significantly increase nephrotoxicity risk 1, 4

Trough Monitoring Protocol

Draw the first trough level immediately before the fourth or fifth dose (approximately 48-60 hours after initiation) to ensure steady-state conditions. 1

Timing is critical: The trough must be drawn within 30 minutes before the next scheduled dose administration. 1

Ongoing monitoring frequency: 1

• Recheck trough with each dose adjustment
• Monitor serum creatinine at least twice weekly throughout therapy
• For stable patients on prolonged therapy, recheck trough weekly

Management of Abnormal Trough Levels

If trough exceeds 20 mg/L: 1, 5

• Immediately hold the next scheduled dose
• Recheck trough level before administering any subsequent doses
• Once trough decreases to 15-20 mg/L, resume vancomycin at reduced dose (reduce by 15-20%) or extend dosing interval

If trough is subtherapeutic (<15 mg/L for serious infections): 1

• Increase dose by 15-20% or shorten dosing interval
• Recheck trough before fourth dose after adjustment

Special Considerations for Elderly Patients

Age-related factors requiring attention: 2

• Greater dosage reductions than expected may be necessary due to decreased renal function
• Elderly patients may have reduced muscle mass affecting creatinine production, potentially overestimating actual renal function 3
• Use actual body weight for dosing calculations in non-obese patients 3

Monitor closely for nephrotoxicity, defined as multiple increases in serum creatinine of 0.5 mg/dL or 150% increase from baseline. 1, 5

Critical Pitfalls to Avoid

Never round SCr to 1.0 mg/dL in elderly patients with actual values <1 mg/dL—this practice significantly underestimates CrCl and leads to underdosing, particularly problematic in elderly females. 3

Never continue the same dose when trough exceeds 20 mg/L—this dramatically increases nephrotoxicity risk even in patients with normal baseline renal function. 1, 5

Never rely on peak level monitoring—it provides no clinical value and is not recommended. 1

Never use vancomycin when MIC ≥2 mg/L—target AUC/MIC ratios are not achievable with conventional dosing; switch to alternative therapy. 1, 5

Nephrotoxicity Risk Factors in This Patient

Monitor especially closely given: 6

• Age 68 years (increasing age associated with increased nephrotoxicity risk)
• Higher vancomycin doses required for serious infections
• Duration of therapy (risk increases with prolonged treatment)

Concomitant nephrotoxic agents significantly increase risk—avoid or use with extreme caution. 6